tiprankstipranks
Telix Pharmaceuticals Ltd. (TLPPF)
OTHER OTC:TLPPF
US Market
TLPPF
Telix Pharmaceuticals
RESEARCH TOOLSreports

Telix Pharmaceuticals (TLPPF) Ratios

191 Followers

Telix Pharmaceuticals Ratios

TLPPF's free cash flow for Q2 2026 was AU$0.52. For the 2026 fiscal year, TLPPF's free cash flow was decreased by AU$ and operating cash flow was AU$-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.01 1.43 2.78 1.48 2.02
Quick Ratio
 1.85 1.27 2.66 1.37 1.93
Cash Ratio
 1.04 0.61 2.15 0.78 1.36
Solvency Ratio
 0.08 0.02 0.06 0.05 -0.55
Operating Cash Flow Ratio
 -0.06 -0.08 0.13 0.15 -0.75
Short-Term Operating Cash Flow Coverage
 -0.97 -1.37 2.27 24.78 -99.80
Net Current Asset Value
AU$ -557.38MAU$ -654.50MAU$ -29.65MAU$ -16.89MAU$ -5.20M
Leverage Ratios
Debt-to-Assets Ratio
 0.43 0.39 0.38 0.04 0.04
Debt-to-Equity Ratio
 1.19 1.12 1.02 0.12 0.13
Debt-to-Capital Ratio
 0.54 0.53 0.51 0.10 0.12
Long-Term Debt-to-Capital Ratio
 0.51 0.49 0.49 0.05 0.04
Financial Leverage Ratio
 2.79 2.85 2.67 2.67 3.19
Debt Service Coverage Ratio
 1.25 0.76 2.01 12.79 -93.88
Interest Coverage Ratio
 -0.51 0.48 3.83 51.99 -180.25
Debt to Market Cap
 0.13 0.16 0.07 <0.01 <0.01
Interest Debt Per Share
 2.52 2.24 1.82 0.06 0.03
Net Debt to EBITDA
 10.48 7.94 -1.47 -4.61 1.14
Profitability Margins
Gross Profit Margin
52.16%53.11%65.08%62.56%18.32%
EBIT Margin
-0.73%2.21%10.46%3.23%-61.35%
EBITDA Margin
3.45%4.92%11.18%4.57%-57.99%
Operating Profit Margin
-0.73%2.21%10.49%10.32%-45.71%
Pretax Profit Margin
3.13%-0.66%7.16%0.61%-61.60%
Net Profit Margin
3.60%-0.89%6.37%1.04%-65.01%
Continuous Operations Profit Margin
3.60%-0.89%6.37%1.04%-65.01%
Net Income Per EBT
115.15%135.30%89.05%168.80%105.53%
EBT Per EBIT
-427.88%-29.64%68.25%5.95%134.77%
Return on Assets (ROA)
2.40%-0.62%3.29%1.31%-40.76%
Return on Equity (ROE)
7.11%-1.77%8.79%3.50%-130.09%
Return on Capital Employed (ROCE)
-0.59%1.93%6.93%21.54%-43.10%
Return on Invested Capital (ROIC)
-0.58%1.90%6.06%20.75%-41.50%
Return on Tangible Assets
4.21%-1.25%4.54%1.81%-54.53%
Earnings Yield
0.85%-0.29%0.61%0.16%-4.61%
Efficiency Ratios
Receivables Turnover
 5.33 6.01 4.93 6.32 3.49
Payables Turnover
 2.57 5.44 3.98 5.73 7.78
Inventory Turnover
 11.13 10.51 7.17 10.87 15.43
Fixed Asset Turnover
 7.00 7.19 14.42 16.48 8.50
Asset Turnover
 0.67 0.70 0.52 1.26 0.63
Working Capital Turnover Ratio
 5.21 3.39 2.36 6.17 3.29
Cash Conversion Cycle
 -40.69 28.37 33.32 27.65 81.44
Days of Sales Outstanding
 68.50 60.76 74.10 57.77 104.69
Days of Inventory Outstanding
 32.80 34.72 50.90 33.58 23.66
Days of Payables Outstanding
 141.99 67.11 91.67 63.70 46.91
Operating Cycle
 101.30 95.48 125.00 91.35 128.35
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.06 -0.08 0.13 0.07 -0.21
Free Cash Flow Per Share
 -0.26 -0.25 0.03 0.04 -0.25
CapEx Per Share
 0.20 0.17 0.10 0.03 0.04
Free Cash Flow to Operating Cash Flow
 4.11 3.19 0.21 0.55 1.22
Dividend Paid and CapEx Coverage Ratio
 -0.32 -0.46 1.26 2.21 -4.62
Capital Expenditure Coverage Ratio
 -0.32 -0.46 1.26 2.21 -4.62
Operating Cash Flow Coverage Ratio
 -0.03 -0.04 0.07 1.37 -6.12
Operating Cash Flow to Sales Ratio
 -0.02 -0.02 0.05 0.05 -0.40
Free Cash Flow Yield
-1.59%-2.26%0.11%0.41%-3.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 119.54 -342.51 164.07 617.41 -21.70
Price-to-Sales (P/S) Ratio
 4.27 3.04 10.41 6.40 14.11
Price-to-Book (P/B) Ratio
 7.96 6.08 14.35 21.61 28.23
Price-to-Free Cash Flow (P/FCF) Ratio
 -63.09 -44.20 906.02 245.79 -29.02
Price-to-Operating Cash Flow Ratio
 -259.68 -141.11 189.44 134.71 -35.30
Price-to-Earnings Growth (PEG) Ratio
 -0.42 2.81 0.20 -5.88 -1.57
Price-to-Fair Value
 7.96 6.08 14.35 21.61 28.23
Enterprise Value Multiple
 134.35 69.64 91.60 135.49 -23.19
Enterprise Value
 6.04B 4.27B 8.02B 3.11B 2.15B
EV to EBITDA
 133.67 69.64 91.60 135.49 -23.19
EV to Sales
 4.61 3.43 10.24 6.19 13.45
EV to Free Cash Flow
 -68.08 -49.89 891.69 237.70 -27.66
EV to Operating Cash Flow
 -279.87 -159.27 186.45 130.28 -33.65
Tangible Book Value Per Share
 -0.41 -0.79 0.46 0.12 0.04
Shareholders’ Equity Per Share
 2.08 1.84 1.72 0.47 0.26
Tax and Other Ratios
Effective Tax Rate
 -0.15 -0.35 0.11 -0.69 -0.06
Revenue Per Share
 3.86 3.69 2.36 1.57 0.52
Net Income Per Share
 0.14 -0.03 0.15 0.02 -0.34
Tax Burden
 1.15 1.35 0.89 1.69 1.06
Interest Burden
 -4.28 -0.30 0.68 0.19 1.00
Research & Development to Revenue
 0.24 0.21 0.25 0.26 0.36
SG&A to Revenue
 0.31 0.29 0.30 0.16 0.31
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.02 0.05
Income Quality
 -0.46 2.43 0.86 4.58 0.61
Currency in AUD